Specialties
Education
- MD, University of Maryland School of Medicine, College Park, MD
- Residency, Johns Hopkins University, Baltimore, MD
- Instructor, Johns Hopkins University, Baltimore, MD
- Fellow, University of California, San Francisco, San Francisco, CA
Clinical Specialties
Dr. Bigelow is a fellowship-trained facial plastic and reconstruction surgeon, with training in the full spectrum of facial aesthetic surgery and reconstruction of acquired or malignant defects of the head and neck. Her reconstructive areas of expertise include the comprehensive surgical and non-surgical management of facial paralysis, Mohs (skin cancer) reconstruction, facial gender affirmation surgery, microtia repair, maxillofacial trauma, and head and neck cancer reconstruction. Her cosmetic interests include rhinoplasty, eyelid surgery, brow lift, facelift, and non-surgical treatments such as skin resurfacing and injectables. Dr. Bigelow strives to work together with her patients to understand their goals and desires, with the goal of selecting the right treatment plan to achieve lasting and safe results.
provides a wide range of services including Blepharoplasty, Botox, Brow Lift, Cheek Implants, Chin Augmentation, Earlobe Repair, Ear Surgery (Otoplasty), Face Lift, Facial Nerve Repair, Filler Injections, Hairline Contouring/Lowering, Laser Resurfacing, Lip Augmentation, Mini-face Lift, Mid-face Lift, Maxillofacial Trauma Repair, Microvascular Reconstruction, Neck Lift, Reconstructive Rhinoplasty, Rhinoplasty, Scar Revision, Septoplasty, Skin Cancer Reconstruction.
Research Interests
Dr. Bigelow is interested in treatment decision making and shared decision making among patients and clinicians, particularly as it pertains to patients with facial paralysis and for transgender and gender-diverse individuals. She also has a strong interest in training the next generation of facial plastic and reconstructive surgeons.
Recent Publications
Ergonomic Assessment of Septorhinoplasty Maneuvers During Simulated Pregnancy.
Bhethanabotla RM, Ledgister K, Soriano IS, O'Sullivan P, Bigelow E, Knott PD, Park AM
OTO Open 2024; 8(2): e126
[PubMed ID: 38577238]Oral Human Papillomavirus Associated With Differences in Oral Microbiota Beta Diversity and Microbiota Abundance.
Zhang Y, D'Souza G, Fakhry C, Bigelow EO, Usyk M, Burk RD, Zhao N
J Infect Dis 2022 Sep 21; 226(6): 1098-1108
[PubMed ID: 35038733]Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
Scott-Wittenborn N, D'Souza G, Tewari S, Rooper L, Troy T, Drake V, Bigelow EO, Windon MJ, Ryan WR, Ha PK, Kiess AP, Miles B, Westra WH, Mydlarz WK, Eisele DW, Fakhry C
Cancer 2022 May 01; 128(9): 1767-1774
[PubMed ID: 35132635]Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.
Bigelow EO, Windon MJ, Fakhry C, Kiess AP, Seiwert T, D'Souza G
Oral Oncol 2021 Dec; 123: 105618
[PubMed ID: 34823157]Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
Bigelow EO, Harris J, Fakhry C, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Frank SJ, Nair SG, Bahig H, Ridge JA, Caudell J, Donaldson C, Clifford BT, Shenouda G, Birrer MJ, Chen Y, Le QT
Head Neck 2022 Jan; 44(1): 158-167
[PubMed ID: 34729846]